| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |